News Title

40 potential unicorns in healthtech (selected from more than 160 top-level companies from 25 counties) will have direct contact to innovation drivers from Europe, and foster vital relationships with 80+ international investors and corporate partners in interactive sessions and networking events at the Tech Tour 2018 Healthtech Summit, taking place on the 25-27 of June in Lausanne, Switzerland.


The Summit is the leading independent platform for digital health and medtech companies to collaborate with international investors and corporate strategic partnering and venturing executives. The event offers entrepreneurs direct access to a unique circle of top ranking investors and strategic corporate partners, facilitating investment and partnerships with the potential to impact the global digital health and medtech landscape.


“No one can afford to ignore the power of emerging and disruptive technologies and the fearless combination of smart thinking (hint: start-ups), smart capital (hint: VC), deep pockets and a long-term vision (hint: tech giants). The Healthtech Summit 2018 is where those worlds meet." – Marco Mohwinckel, Chief Commercial Officer at COMPASS Pathways, Pharma & HealthTech Advisor and President of the Tech Tour 2018 Healthtech Summit.


This is the 9th edition of the Summit and since first launching in 2008 HTS companies have raised over €1.3 billion in private funding, in addition to €540 million in M&A with many companies acquired by Tech Tour community members who participated in the events. Total IPO has doubled each year since 2008 and is currently valued at €182 million. The biggest success stories to date include MindMaze, who raised €100 million and went on to become Switzerland’s first unicorn. Sapiens Steering Brain Stimulation who presented in 2015 were acquired by Medtronic for €200 million. Medopad presented in 2016 and raised €23 million as part of a €98 million funding round closing in 2018. Other companies include Endosense, acquired by St. June Medical for €171 million and Symetis, acquired by Boston Scientific for €408 million.


This year’s speakers represent major actors in the healthtech industry including from: Ambu, American Well, Bayer, Boston Scientific, Draper Esprit, Johnson & Johnson, Kaia Health, KPMG, Medopad, Medtronic EMEA, Merck GHI, Roche, Voluntis, and many more. See the full programme here.


The Summit will also recognise 3 success story companies at an Awards Ceremony held on the evening of the 26 June during the Summit gala networking dinner, to award the Tech Tour 2018 Digital Health Award, Medtech Award, and Special Jury Prize. Past Award Winners include: eDevice, Symetis, Neuravi, MindMaze, Cequr, Occlutech, EOS, Endosense, Sapiens Steering Brain Stimulation and Sophia Genetics.


The Summit is organised by Tech Tour, a company with more than 20-years of experience in organising events, the main goal of which is helping entrepreneurs and investors work together and realise their full journey of innovation, from the initial concept all the way through to valuation. The Summit is also supported by the International Venture Club (IVC) of leading independent venture capital, corporate and institutional investors promoting successful international investments.


The deadline for participants to register to attend is the 25 June 2018. Please visit for more information.


Notes to editors

Media representatives can register for the Healthtech Summit free of charge up to the 25 June 2018 – via email or the media registration on the HTS event website.


We have exciting media partnership opportunities for the 2018 edition. If you are interested email us to receive additional information.


About Tech Tour

Founded in 1998, Tech Tour is a community with strong positions in the venture capital market. We promote innovative companies and their projects through our online community platform and in person at 25 networking events that we organise each year. We have 20-years of experience across Europe and the Middle East and present a unique cross-border platform for growing and emerging innovative tech companies on their way to investment and funding – from the idea to the success story. For more information please see:


About the International Venture Club

The International Venture Club is a collaborative platform of over 70 leading independent venture capital, corporate and institutional investors promoting successful international investments. The Club objectives are to share better practices, build co-investor trust and relations, foster new funding and investment opportunities through joint actions and grow portfolio companies with corporate partners and co-investors. The International Venture Club is managed by Tech Tour. For more information please see:


Contact: Stephanie de Verteuil | |